LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION March 25, 2025 TO: Honorable Cole Hefner, Chair, House Committee on Homeland Security, Public Safety & Veterans' Affairs FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: HB1837 by Guillen (Relating to the enforcement and prevention of offenses involving the manufacture or delivery of controlled substances listed in Penalty Group 1-B, law enforcement officer safety in handling those substances, and the manufacture and proper use of opioid antagonists.), As Introduced No significant fiscal implication to the State is anticipated. It is assumed that any costs associated with the bill could be absorbed using existing resources. Local Government ImpactNo significant fiscal implication to units of local government is anticipated. Source Agencies: b > td > 212 Office of Court Administration, Texas Judicial Council, 300 Trusteed Programs Within the Office of the Governor, 405 Department of Public Safety, 407 Commission on Law Enforcement, 529 Health and Human Services Commission LBB Staff: b > td > JMc, MGol, CSh, KVEL
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION
March 25, 2025
TO: Honorable Cole Hefner, Chair, House Committee on Homeland Security, Public Safety & Veterans' Affairs FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: HB1837 by Guillen (Relating to the enforcement and prevention of offenses involving the manufacture or delivery of controlled substances listed in Penalty Group 1-B, law enforcement officer safety in handling those substances, and the manufacture and proper use of opioid antagonists.), As Introduced
TO: Honorable Cole Hefner, Chair, House Committee on Homeland Security, Public Safety & Veterans' Affairs
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: HB1837 by Guillen (Relating to the enforcement and prevention of offenses involving the manufacture or delivery of controlled substances listed in Penalty Group 1-B, law enforcement officer safety in handling those substances, and the manufacture and proper use of opioid antagonists.), As Introduced
Honorable Cole Hefner, Chair, House Committee on Homeland Security, Public Safety & Veterans' Affairs
Honorable Cole Hefner, Chair, House Committee on Homeland Security, Public Safety & Veterans' Affairs
Jerry McGinty, Director, Legislative Budget Board
Jerry McGinty, Director, Legislative Budget Board
HB1837 by Guillen (Relating to the enforcement and prevention of offenses involving the manufacture or delivery of controlled substances listed in Penalty Group 1-B, law enforcement officer safety in handling those substances, and the manufacture and proper use of opioid antagonists.), As Introduced
HB1837 by Guillen (Relating to the enforcement and prevention of offenses involving the manufacture or delivery of controlled substances listed in Penalty Group 1-B, law enforcement officer safety in handling those substances, and the manufacture and proper use of opioid antagonists.), As Introduced
No significant fiscal implication to the State is anticipated.
No significant fiscal implication to the State is anticipated.
It is assumed that any costs associated with the bill could be absorbed using existing resources.
Local Government Impact
No significant fiscal implication to units of local government is anticipated.
Source Agencies: b > td > 212 Office of Court Administration, Texas Judicial Council, 300 Trusteed Programs Within the Office of the Governor, 405 Department of Public Safety, 407 Commission on Law Enforcement, 529 Health and Human Services Commission
212 Office of Court Administration, Texas Judicial Council, 300 Trusteed Programs Within the Office of the Governor, 405 Department of Public Safety, 407 Commission on Law Enforcement, 529 Health and Human Services Commission
LBB Staff: b > td > JMc, MGol, CSh, KVEL
JMc, MGol, CSh, KVEL